Patents by Inventor Frédéric MATHOT

Frédéric MATHOT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation
    Patent number: 11590243
    Abstract: The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: February 28, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Erwan Bourles, Olivier Despas, Delphine Guillaume, Frederic Mathot, Mathieu Vasselle
  • VACCINE
    Publication number: 20220152182
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to immunogenic compositions and vaccines comprising detoxified pneumolysin adsorbed onto aluminium phosphate and an improved process for the adsorption of detoxified pneumolysin onto aluminium phosphate. It additionally relates to the use of the immunogenic compositions and vaccines in the treatment or prevention of Streptococcus pneumoniae infection.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Laurence Danielle GHENNE, Dominique Ingrid LEMOINE, Frédéric MATHOT, Florence Emilie Jeanne Francoise WAUTERS
  • Vaccine
    Patent number: 11266731
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to immunogenic compositions and vaccines comprising detoxified pneumolysin adsorbed onto aluminium phosphate and an improved process for the adsorption of detoxified pneumolysin onto aluminium phosphate. It additionally relates to the use of the immunogenic compositions and vaccines in the treatment or prevention of Streptococcu pneumoniae infection.
    Type: Grant
    Filed: February 20, 2017
    Date of Patent: March 8, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Laurence Danielle Ghenne, Dominique Ingrid Lemoine, Frédéric Mathot, Florence Emilie Jeanne Francoise Wauters
  • VACCINE
    Publication number: 20210187090
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, the present invention relates to immunogenic compositions and vaccines comprising detoxified pneumolysin adsorbed onto aluminium phosphate and an improved process for the adsorption of detoxified pneumolysin onto aluminium phosphate. It additionally relates to the use of the immunogenic compositions and vaccines in the treatment or prevention of Streptococcu pneumoniae infection.
    Type: Application
    Filed: February 20, 2017
    Publication date: June 24, 2021
    Inventors: Laurence Danielle GHENNE, Dominique Ingrid LEMOINE, Frédéric MATHOT, Florence Emilie Jeanne Francoise WAUTERS
  • Pharmaceutical composition comprising an adenoviral vector
    Patent number: 10722470
    Abstract: The present invention relates to the formulation of Adenoviral vectors in an aqueous mixture or freeze dried composition in the presence of amorphous sugar and low salt concentration, its formulation as well as a method for obtaining the dried composition.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: July 28, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Erwan Bourles, Frederic Mathot
  • NOVEL FORMULATION
    Publication number: 20190365930
    Abstract: The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 5, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Erwan BOURLES, Olivier DESPAS, Delphine GUILLAUME, Frederic MATHOT, Mathieu VASSELLE
  • PHARMACEUTICAL COMPOSITION COMPRISING AN ADENOVIRAL VECTOR
    Publication number: 20180214379
    Abstract: The present invention relates to the formulation of Adenoviral vectors in an aqueous mixture or freeze dried composition in the presence of amorphous sugar and low salt concentration, its formulation as well as a method for obtaining the dried composition.
    Type: Application
    Filed: July 20, 2016
    Publication date: August 2, 2018
    Applicant: GlaxoSmithKline Biologicals, S.A.
    Inventors: Erwan BOURLES, Frederic MATHOT
  • INACTIVATED DENGUE VIRUS VACCINE
    Publication number: 20140112953
    Abstract: The present invention provides formulations of an immunogenic composition containing a purified inactivated Dengue virus, and method for producing them.
    Type: Application
    Filed: May 25, 2012
    Publication date: April 24, 2014
    Applicant: Glaxo SmithKline Biologicals sa
    Inventors: Veronique Henderickx, Olivier Le Bussy, Dominique Ingrid Lemoine, Frederic Mathot